{"address1": "2500 Westchester Ave.", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 854148, "exercisedValue": 0, "unexercisedValue": 559838}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 414884, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 616275, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven A. Weissman Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anita  Cornet", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bobby  Horn", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4208, "open": 0.419, "dayLow": 0.39, "dayHigh": 0.435, "regularMarketPreviousClose": 0.4208, "regularMarketOpen": 0.419, "regularMarketDayLow": 0.39, "regularMarketDayHigh": 0.435, "payoutRatio": 0.0, "beta": 1.026, "forwardPE": -0.5092208, "volume": 1808410, "regularMarketVolume": 1808410, "averageVolume": 1596505, "averageVolume10days": 691100, "averageDailyVolume10Day": 691100, "bid": 0.3904, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 24299574, "fiftyTwoWeekLow": 0.34, "fiftyTwoWeekHigh": 2.95, "fiftyDayAverage": 0.5484, "twoHundredDayAverage": 0.772205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 104592, "profitMargins": 0.0, "floatShares": 55626916, "sharesOutstanding": 61972900, "sharesShort": 1416555, "sharesShortPriorMonth": 222751, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.023699999, "heldPercentInsiders": 0.02241, "heldPercentInstitutions": 0.17894, "shortRatio": 0.5, "shortPercentOfFloat": 0.0298, "impliedSharesOutstanding": 61972900, "bookValue": 0.313, "priceToBook": 1.2527157, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -33971000, "trailingEps": -0.86, "forwardEps": -0.77, "enterpriseToEbitda": -0.002, "52WeekChange": -0.80101526, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.3921, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.4, "targetMedianPrice": 5.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 25009000, "totalCashPerShare": 0.404, "ebitda": -53859000, "totalDebt": 814000, "quickRatio": 2.486, "currentRatio": 2.653, "debtToEquity": 4.341, "returnOnAssets": -1.03151, "returnOnEquity": -1.5718601, "freeCashflow": -28761376, "operatingCashflow": -28474000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CGTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_39366358", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743594157, "regularMarketTime": 1743537602, "regularMarketChangePercent": -6.8203406, "regularMarketPrice": 0.3921, "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1633699800000, "preMarketChange": 0.002000004, "preMarketChangePercent": 0.510075, "preMarketPrice": 0.3941, "regularMarketChange": -0.028699994, "regularMarketDayRange": "0.39 - 0.435", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1596505, "fiftyTwoWeekLowChange": 0.052100003, "fiftyTwoWeekLowChangePercent": 0.1532353, "fiftyTwoWeekRange": "0.34 - 2.95", "fiftyTwoWeekHighChange": -2.5579, "fiftyTwoWeekHighChangePercent": -0.86708474, "fiftyTwoWeekChangePercent": -80.101524, "earningsTimestamp": 1742468426, "earningsTimestampStart": 1742468426, "earningsTimestampEnd": 1742468426, "earningsCallTimestampStart": 1742472000, "earningsCallTimestampEnd": 1742472000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.86, "epsForward": -0.77, "epsCurrentYear": -0.4, "priceEpsCurrentYear": -0.98025, "fiftyDayAverageChange": -0.15629998, "fiftyDayAverageChangePercent": -0.2850109, "twoHundredDayAverageChange": -0.380105, "twoHundredDayAverageChangePercent": -0.49223328, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-08", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Cognition Therapeutics", "trailingPegRatio": null}